Greer''s Sublingual-Oral Immunotherapy Clinical Trials Support The Safety Of Home Administration Of Allergy Immunotherapy

... Greer reported results of PhaseI safety and dosing trials for the sublingual-oral immunotherapyadministration of its standardized dust mite, short ragweed, Timothy grass andcat hair extracts at the American Academy of Allergy Asthma and Immunology(AAAAI) annual meeting. Dr. Bob Esch, Vice President of Research andDevelopment for Greer, presented the findings of Greer''s clinical trials atthe meeting, which was held March 3-7 at the Miami Beach Conference Center inMiami Beach, Fla... click link for more info. ...